tobira therapeutics inc
(TBRA:Consolidated Issue listed on NASDAQ Capital Market)
Andrew Asa Hindman M.B.A
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 3 different industries.|
As of Fiscal Year 2013
Mr. Andrew Asa Hindman M.B.A has been the Chief Business Development Officer of Acorda Therapeutics, Inc. since May 2014. Mr. Hindman held several senior executive level positions in the biopharmaceutical industry. Mr. Hindman served as the Chief Executive Officer and President of Tobira Therapeutics, Inc. since April 2011. At Tobira, he was responsible for developing a new corporate strategy, building new leadership and operational teams, and raising operating capital. ...
701 Gateway boulevardPhone: 650-741-6625
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Columbia Business School
|James E. Brown D.V.M.||Co-Founder, Chief Executive Officer, President and Director|
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Stephen R. Davis J.D.||Interim Chief Executive Officer, Chief Financial Officer, Executive Vice President and Chief Business Officer|
ACADIA Pharmaceuticals Inc.
|$245.6K||Compensation as of Fiscal Year 2014.|